Evidence map›Paper›PMID 21756872›Full record

ReviewBiochimica et biophysica acta2011

The cytochrome bd respiratory oxygen reductases.

Vitaliy B Borisov, Robert B Gennis, James Hemp, Michael I Verkhovsky

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 271 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 1 synthesis or guideline pooled it, 511 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Aerotolerant capacity of the lung symbiontJournal of bacteriology · 2026
    Article
  5. Review
  6. Article
  7. Microorganisms · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Investigating the role of cytochromeRSC medicinal chemistry · 2026
    Article
  12. TheProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Transcriptome-Based Analysis of the Oxidative Response ofCombinatorial chemistry & high throughput screening · 2026
    Article
  18. Article
  19. Article
  20. Article

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Vitaliy B BorisovBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow 119991, Russian Federation. bor@genebee.msu.su
Robert B Gennis
James Hemp
Michael I Verkhovsky
University of Illinois Urbana-Champaign · USLomonosov Moscow State University · RUUniversity of Helsinki · FI

Funding

PROTEIN/LIPID INTERACTIONSR01HL016101 · NHLBI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI GENNIS, ROBERT B · 1985 to 2015
$6.8M
PROTEIN/LIPID INTERACTIONSR37HL016101 · NHLBI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI GENNIS, ROBERT B. · 1993 to 2002
$1.5M
NHLBI NIH HHS HL16101NHLBI NIH HHS R01 HL016101NHLBI NIH HHS R37 HL016101
6 · The paper itself

Abstract

Cytochrome bd is a respiratory quinol: O₂ oxidoreductase found in many prokaryotes, including a number of pathogens. The main bioenergetic function of the enzyme is the production of a proton motive force by the vectorial charge transfer of protons. The sequences of cytochromes bd are not homologous to those of the other respiratory oxygen reductases, i.e., the heme-copper oxygen reductases or alternative oxidases (AOX). Generally, cytochromes bd are noteworthy for their high affinity for O₂ and resistance to inhibition by cyanide. In E. coli, for example, cytochrome bd (specifically, cytochrome bd-I) is expressed under O₂-limited conditions. Among the members of the bd-family are the so-called cyanide-insensitive quinol oxidases (CIO) which often have a low content of the eponymous heme d but, instead, have heme b in place of heme d in at least a majority of the enzyme population. However, at this point, no sequence motif has been identified to distinguish cytochrome bd (with a stoichiometric complement of heme d) from an enzyme designated as CIO. Members of the bd-family can be subdivided into those which contain either a long or a short hydrophilic connection between transmembrane helices 6 and 7 in subunit I, designated as the Q-loop. However, it is not clear whether there is a functional consequence of this difference. This review summarizes current knowledge on the physiological functions, genetics, structural and catalytic properties of cytochromes bd. Included in this review are descriptions of the intermediates of the catalytic cycle, the proposed site for the reduction of O₂, evidence for a proton channel connecting this active site to the bacterial cytoplasm, and the molecular mechanism by which a membrane potential is generated.

Indexed as

CatalysisCell RespirationCytochromesElectron Transport Chain Complex ProteinsEnzyme InhibitorsHumansOxidation-ReductionOxidoreductasesPhylogenyProtein BindingProtein ConformationCytochromesElectron Transport Chain Complex ProteinsEnzyme InhibitorsOxidoreductases

Identifiers

PMID21756872
PMCPMC3171616
OpenAlexW1988857358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.